About ProQinase

ProQinase GmbH was founded in 2001 as a 100% subsidiary of the Tumor Biology Center Freiburg, which is one of the largest privately owned hospitals of this type in Europe. ProQinase has been growing steadily over the past years. It has meanwhile a personal of 33 and offers its Integrated Protein Kinase Technology Platform, which is uniquely designed for drug development targeting protein kinases in cancer. It features the complete preclinical drug discovery cycle and even, due to ProQinase’s affiliation, rapid access to clinical trials in the private cancer hospital.

Facts about ProQinase
  • Focus : Service
  • Industry : Biotechnology

Here you will find ProQinase GmbH

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 products
1 whitepaper
1 brochures
View topic world
Topic world Diagnostics

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 products
1 whitepaper
1 brochures